Dohj, LLC Biogen Inc. Transaction History

Dohj, LLC

$436 Million
Q1 2025

A detailed history of Dohj, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Dohj, LLC holds 8,592 shares of BIIB stock, worth $1 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

8,592

Previous 8,753 1.84%

Holding current value

$1 Million

Previous $1.34 Million 12.18%

% of portfolio

0.27%

Previous 0.31%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	SELL	$133.43 - $153.27 $21,482 - $24,676	-161 Reduced 1.84%	8,592 $1.18 Million
Q4 2024 Jan 23, 2025	SELL	$146.47 - $191.55 $107,948 - $141,172	-737 Reduced 7.77%	8,753 $1.34 Million
Q3 2024 Oct 15, 2024	BUY	$189.07 - $236.8 $294,571 - $368,934	1,558 Added 19.64%	9,490 $1.84 Million
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $262,155 - $325,726	1,376 Added 20.99%	7,932 $1.84 Million
Q1 2024 Apr 15, 2024	BUY	$212.02 - $267.71 $610,829 - $771,272	2,881 Added 78.39%	6,556 $1.41 Million
Q4 2023 Feb 02, 2024	BUY	$222.59 - $267.94 $818,018 - $984,679	3,675 New	3,675 $950,000

Others Institutions Holding BIIB

# of Institutions

1,015

Shares Held

127M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $16.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dohj, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dohj, LLC with notifications on news.

Account